Abicipar Pegol
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Abicipar Pegol, covering 2015-07-14 to 2020-08-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD) [Phase 2]